Tag: Tremelimumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Tremelimumab

AstraZeneca Shares Data at EASL and ESMO World GI for IMFINZI® (durvalumab ... - Yahoo Finance

Added to Collection on: 2022-07-01 13:07:26

Tags for this article:

Cancer
Clinical medicine
Health
Orphan drugs
Monoclonal antibodies
Breakthrough therapy
Lung cancer
Infectious causes of cancer
Durvalumab
Cholangiocarcinoma
Tremelimumab
Sorafenib
Gemcitabine
Cisplatin
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
AstraZeneca aims to transform cancer outcomes with new data across industry ... - Cision News

Added to Collection on: 2022-08-24 06:02:43

Tags for this article:

Clinical medicine
Medicine
Cancer treatments
Genentech
Monoclonal antibodies
Durvalumab
AstraZeneca
Lung cancer
PARP inhibitor
Trastuzumab emtansine
Tremelimumab
Cancer immunotherapy

Click the tags to see associated articles and topics

View Article Details
Imfinzi and tremelimumab with chemotherapy demonstrated sustained survival benefit

Added to Collection on: 2022-09-11 08:24:43

Tags for this article:

Lung cancer
Cancer
Clinical medicine
Medicine
Durvalumab
Non-small-cell lung carcinoma
Small-cell carcinoma
KRAS
Chemotherapy
Treatment of lung cancer
Adenocarcinoma of the lung
Tremelimumab
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
Imjudo (tremelimumab) in combination with Imfinzi approved in the US for patients with ...

Added to Collection on: 2022-10-24 07:13:59

Tags for this article:

Cancer
Medicine
Clinical medicine
Cancer treatments
Lung cancer
Hepatology
RTT
Infectious causes of cancer
Durvalumab
Cancer immunotherapy
PD-1 and PD-L1 inhibitors
Tremelimumab
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
Imjudo (tremelimumab) in combination with Imfinzi approved in the US for patients ... - Cision News

Added to Collection on: 2022-10-24 06:04:31

Tags for this article:

Cancer
Medicine
Clinical medicine
RTT
Cancer treatments
Lung cancer
Hepatology
Infectious causes of cancer
Durvalumab
Cancer immunotherapy
PD-1 and PD-L1 inhibitors
Tremelimumab
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
US FDA grants approval for AstraZeneca's combination liver cancer therapy

Added to Collection on: 2022-10-25 13:14:53

Tags for this article:

Clinical medicine
Medicine
Cancer treatments
Cancer
Monoclonal antibodies
Durvalumab
PD-1 and PD-L1 inhibitors
Tremelimumab
Sorafenib
AstraZeneca
Treatment of cancer
Cancer immunotherapy

Click the tags to see associated articles and topics

View Article Details
FDA Approves AstraZeneca's Imjudo for Combination Liver Cancer Treatment - PharmTech

Added to Collection on: 2022-10-26 21:07:48

Tags for this article:

Medicine
Clinical medicine
Cancer
Hepatology
Cancer treatments
Durvalumab
Sorafenib
Hepatocellular carcinoma
Tremelimumab
Liver cancer
AstraZeneca
Brivanib alaninate

Click the tags to see associated articles and topics

View Article Details
Immunotherapy Before Surgery May Improve Outcomes for Mesothelioma - Cure Today

Added to Collection on: 2022-12-24 14:08:12

Tags for this article:

Clinical medicine
Cancer
Medicine
Cancer treatments
RTT
Monoclonal antibodies
Infectious causes of cancer
Virotherapy
Durvalumab
Mesothelioma
Tremelimumab
Immunotherapy
Baylor College of Medicine
Bryan M. Burt

Click the tags to see associated articles and topics

View Article Details
AstraZeneca gets Japanese approval for Imfinzi, Imjudo to treat 3 types of cancer

Added to Collection on: 2022-12-28 08:14:20

Tags for this article:

Medicine
Medical specialties
Clinical medicine
Hepatology
Monoclonal antibodies
Infectious causes of cancer
Durvalumab
Cancer treatments
Immune system
Tremelimumab
PD-L1
Programmed cell death protein 1

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Imfinzi combination shows promise in phase 3 liver cancer study - PMLiVE

Added to Collection on: 2024-01-23 13:43:45

Tags for this article:

Orphan drugs
Hepatology
Monoclonal antibodies
Infectious causes of cancer
Durvalumab
Hepatocellular carcinoma
Progression-free survival
Liver cancer
Tremelimumab
Bevacizumab
Clinical endpoint
Bland embolization
Avastin
AstraZeneca

Click the tags to see associated articles and topics

View Article Details